CN103933552A - 用于预防糖尿病足截除的微球体药物组合物 - Google Patents

用于预防糖尿病足截除的微球体药物组合物 Download PDF

Info

Publication number
CN103933552A
CN103933552A CN201410189221.8A CN201410189221A CN103933552A CN 103933552 A CN103933552 A CN 103933552A CN 201410189221 A CN201410189221 A CN 201410189221A CN 103933552 A CN103933552 A CN 103933552A
Authority
CN
China
Prior art keywords
microspheres
egf
wound
pharmaceutical composition
microsphere
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410189221.8A
Other languages
English (en)
Chinese (zh)
Inventor
B·Y·贝坦克特罗德里格斯
V·M·赛斯马丁内斯
R·佩斯梅雷莱斯
J·A·贝兰加阿科斯塔
J·A·拉蒙埃尔南德斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro de Ingenieria Genetica y Biotecnologia CIGB
Original Assignee
Centro de Ingenieria Genetica y Biotecnologia CIGB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38185604&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN103933552(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centro de Ingenieria Genetica y Biotecnologia CIGB filed Critical Centro de Ingenieria Genetica y Biotecnologia CIGB
Publication of CN103933552A publication Critical patent/CN103933552A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CN201410189221.8A 2006-01-31 2007-01-29 用于预防糖尿病足截除的微球体药物组合物 Pending CN103933552A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20060021A CU23388B6 (es) 2006-01-31 2006-01-31 Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
CU2006-0021 2006-01-31

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800090345A Division CN101400338A (zh) 2006-01-31 2007-01-29 用于预防糖尿病足截除的微球体药物组合物

Publications (1)

Publication Number Publication Date
CN103933552A true CN103933552A (zh) 2014-07-23

Family

ID=38185604

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201410189221.8A Pending CN103933552A (zh) 2006-01-31 2007-01-29 用于预防糖尿病足截除的微球体药物组合物
CNA2007800090345A Pending CN101400338A (zh) 2006-01-31 2007-01-29 用于预防糖尿病足截除的微球体药物组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA2007800090345A Pending CN101400338A (zh) 2006-01-31 2007-01-29 用于预防糖尿病足截除的微球体药物组合物

Country Status (24)

Country Link
US (1) US8741848B2 (https=)
EP (1) EP1987817B1 (https=)
JP (1) JP5219841B2 (https=)
KR (1) KR101401273B1 (https=)
CN (2) CN103933552A (https=)
AR (1) AR059234A1 (https=)
AT (1) ATE437631T1 (https=)
AU (1) AU2007211753B2 (https=)
BR (1) BRPI0707395A2 (https=)
CA (1) CA2640743C (https=)
CU (1) CU23388B6 (https=)
CY (1) CY1109513T1 (https=)
DE (1) DE602007001786D1 (https=)
DK (1) DK1987817T3 (https=)
ES (1) ES2330688T3 (https=)
HK (1) HK1198743A1 (https=)
MY (1) MY143742A (https=)
PL (1) PL1987817T3 (https=)
PT (1) PT1987817E (https=)
RU (1) RU2426528C2 (https=)
SG (1) SG169366A1 (https=)
SI (1) SI1987817T1 (https=)
WO (1) WO2007087759A2 (https=)
ZA (1) ZA200806648B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106267163A (zh) * 2015-06-09 2017-01-04 济南博创医药科技有限公司 一种治疗皮肤创伤的药物组合物及其药物制剂
CN113727727A (zh) * 2019-03-18 2021-11-30 遗传工程与生物技术中心 表皮生长因子在治疗糖尿病性足溃疡中的用途

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23411B6 (es) * 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético
RU2351334C1 (ru) * 2007-12-04 2009-04-10 Георгий Кимович Золоев Способ лечения хронической ишемии нижних конечностей ii б - iv степени
ES2340902B1 (es) 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
KR101156094B1 (ko) * 2010-02-22 2012-06-20 경상대학교산학협력단 약물송달을 위한 양친성 ＰＨＡ－ｍＰＥＧ 공중합 나노 컨테이너
RU2421221C1 (ru) * 2010-03-22 2011-06-20 Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Способ лечения критической ишемии нижних конечностей различного генеза
RU2425675C1 (ru) * 2010-05-25 2011-08-10 Федеральное государственное учреждение "Нижегородский научно-исследовательский институт травматологии и ортопедии Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения больных с нейропатической и нейроишемической формами синдрома "диабетическая стопа"
ES2357601B1 (es) 2011-01-26 2012-03-21 Laboratorios Farmacéuticos Rovi, S.A. Procedimiento de preparación de derivados de glicosaminoglicanos donadores de óxido n�?trico y su uso en tratamiento de úlceras crónicas.
EP2737895A1 (en) 2012-11-30 2014-06-04 Praxis Pharmaceutical, S.A. Microparticles with EGF, method of preparation and use
EP2821077A1 (en) 2013-07-04 2015-01-07 Praxis Biopharma Research Institute Lipid nanoparticles for wound healing
EP3097922A1 (fr) 2015-05-28 2016-11-30 Denis Barritault Composition pour le traitement des lesions tissulaires
MX389934B (es) * 2016-12-09 2025-03-20 Desarrolladora Y Com De Tecnologias Biomedicas Decotecbio S A De C V Composición coadyuvante de un factor de crecimiento y un neuropéptido para acelerar la cicatrización de heridas y la repitelización de órganos.
KR102218427B1 (ko) * 2017-09-20 2021-02-22 차의과학대학교 산학협력단 단백질 약물을 포함하는 코아세르베이트 조성물 및 이를 포함하는 창상 치료제

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1620308A (zh) * 2001-12-20 2005-05-25 遗传和生物技术工程中心 含有表皮生长因子的药物组合物在预防糖尿病肢端坏疽截肢中的用途
CN1720989A (zh) * 2004-07-15 2006-01-18 深圳市清华源兴生物医药科技有限公司 一种表皮生长因子缓释微球及其制备方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
JP2670680B2 (ja) * 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US5034375A (en) 1988-08-10 1991-07-23 Institute Of Molecular Biology, Inc. Process of wound healing using PDGF and EGF
US4944948A (en) * 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method
AU633078B2 (en) 1989-04-04 1993-01-21 Alcon Laboratories, Inc. The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
CA2038945A1 (en) 1989-08-01 1991-02-02 Norman D. Weiner Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes
AU629316B2 (en) * 1990-04-11 1992-10-01 Flora Inc. Periodontal disease treatment system
US6902743B1 (en) * 1995-05-22 2005-06-07 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
US6132759A (en) * 1996-05-03 2000-10-17 Innogenetics N.V. Medicaments containing gelatin cross-linked with oxidized polysaccharides
WO1997044016A1 (en) * 1996-05-23 1997-11-27 Samyang Corporation Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US5861149A (en) * 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
ES2382636T3 (es) * 2000-10-31 2012-06-12 Surmodics Pharmaceuticals, Inc. Método para producir composiciones para la administración mejorada de moléculas bioactivas
EP1482966B1 (en) 2002-03-12 2014-05-14 Bio-Click Technologies Ltd Method and composition for treating skin wounds with epidermal growth factor
CU23411B6 (es) * 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1620308A (zh) * 2001-12-20 2005-05-25 遗传和生物技术工程中心 含有表皮生长因子的药物组合物在预防糖尿病肢端坏疽截肢中的用途
CN1720989A (zh) * 2004-07-15 2006-01-18 深圳市清华源兴生物医药科技有限公司 一种表皮生长因子缓释微球及其制备方法与应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106267163A (zh) * 2015-06-09 2017-01-04 济南博创医药科技有限公司 一种治疗皮肤创伤的药物组合物及其药物制剂
CN113727727A (zh) * 2019-03-18 2021-11-30 遗传工程与生物技术中心 表皮生长因子在治疗糖尿病性足溃疡中的用途

Also Published As

Publication number Publication date
EP1987817A2 (en) 2008-11-05
CY1109513T1 (el) 2014-08-13
DK1987817T3 (da) 2009-11-30
PT1987817E (pt) 2009-10-26
KR20080096804A (ko) 2008-11-03
MY143742A (en) 2011-07-15
ATE437631T1 (de) 2009-08-15
AR059234A1 (es) 2008-03-19
DE602007001786D1 (de) 2009-09-10
WO2007087759A2 (es) 2007-08-09
CA2640743A1 (en) 2007-08-09
ES2330688T3 (es) 2009-12-14
SG169366A1 (en) 2011-03-30
AU2007211753A1 (en) 2007-08-09
US20090220608A1 (en) 2009-09-03
EP1987817B1 (en) 2009-07-29
US8741848B2 (en) 2014-06-03
AU2007211753B2 (en) 2012-03-01
ZA200806648B (en) 2009-05-27
RU2426528C2 (ru) 2011-08-20
JP2009525288A (ja) 2009-07-09
WO2007087759A3 (es) 2007-09-20
RU2008135354A (ru) 2010-03-10
CU23388B6 (es) 2009-07-16
KR101401273B1 (ko) 2014-05-29
CA2640743C (en) 2012-05-15
CN101400338A (zh) 2009-04-01
JP5219841B2 (ja) 2013-06-26
SI1987817T1 (sl) 2009-12-31
PL1987817T3 (pl) 2010-01-29
HK1198743A1 (en) 2015-06-05
BRPI0707395A2 (pt) 2011-05-03

Similar Documents

Publication Publication Date Title
CN103933552A (zh) 用于预防糖尿病足截除的微球体药物组合物
Kong et al. Biomimetic hydrogel for rapid and scar-free healing of skin wounds inspired by the healing process of oral mucosa
Değim et al. Evaluation of chitosan gel containing liposome‐loaded epidermal growth factor on burn wound healing
Yin et al. γ-PGA hydrogel loaded with cell-free fat extract promotes the healing of diabetic wounds
Brown et al. Enhancement of wound healing by topical treatment with epidermal growth factor
Li et al. A PTHrP-2 loaded adhesive cellulose acetate nanofiber mat as wound dressing accelerates wound healing
US12178940B2 (en) Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation
Xu et al. A multi-purpose dressing based on resveratrol-loaded ionic liquids/gelatin methacryloyl hydrogel for enhancing diabetic wound healing
Wang et al. Promoting coagulation and activating SMAD3 phosphorylation in wound healing via a dual-release thrombin-hydrogel
Xie et al. Dynamically crosslinked protien hydrogel composite as multifunctional wound dressing for cutaneous infection
Yang et al. Therapeutic effect of propolis nanoparticles on wound healing
Aghazadeh et al. Vancomycin prolonged release via PLGA system loaded with drug-containing chitosan nanoparticles as a novel in situ forming drug delivery system
CN117582545A (zh) 一种宫腔修复材料及其制备方法和应用
Wassif et al. Recent advances in the local drug delivery systems for diabetic wound healing: a comprehensive review
CN116531369A (zh) 一种化合物在促进伤口愈合药物中的应用
Adib-Hashemi et al. RETRACTED ARTICLE: Anti-inflammatory and protective investigations on the effects of Theranekron®” an alcoholic extract of the Tarantula cubensis” on wound healing of peritoneal in the rat: an in vivo comparative study
Liu et al. Poly (lactic-co-glycolic acid)-Chitosan–gelatin composite nanomaterials for the treatment of diabetic foot ulcer wound infection
Zehra et al. Electrospun bilayer membranes carrying bearberry/licorice extract to ameliorate wound healing
EP2737895A1 (en) Microparticles with EGF, method of preparation and use
HK1130681A (en) Pharmaceutical composition of microspheres for preventing diabetic foot amputation
JP4578067B2 (ja) 局所医薬組成物
MX2008009943A (en) Pharmaceutical composition of microspheres for preventing diabetic foot amputation
Sanchez et al. Polyelectrolyte Complexes of Ciprofloxacin and Lidocaine Improve Wound Healing in Deep Second Degree Burns and Reduce in Vitro Ciprofloxacin Cytotoxicity in Fibroblasts
JP2001316282A (ja) 生理活性ペプチド含有コラーゲン成形体及びその製法
Hrynyk Enhanced burn wound healing through controlled and sustained delivery of bioactive insulin from alginate sponge dressings

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1198743

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140723

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1198743

Country of ref document: HK